Neuroprotection by mefenamic acid against D-serine: involvement of oxidative stress, inflammation and apoptosis.

Free Radic Res

Department of Biochemistry, Faculty of Pharmacy, Ege University, Bornova, Izmir, Turkey.

Published: June 2012

Mefenamic acid, a non-steroidal antiinflammatory drug (NSAID), directly and dose-dependently exhibits neuroprotective activity. In our study, we investigated the effects of mefenamic acid against d-serine on oxidative stress in the hippocampus, cortex and cerebellum of rats. Furthermore, the potential inflammatory and apoptotic effects of d-serine and potential protective effect of mefenamic acid were determined at mRNA and protein levels of TNF-α, IL-1β, Bcl-2 and Bax. We found that d-serine significantly increased oxidative stress, levels of inflammation- and apoptosis-related molecules in a region specific manner. Mefenamic acid treatment provided significant protection against the elevation of lipid peroxidation, protein oxidation, levels of TNF-α, IL-1β and Bax. As a conclusion, we suggest that d-serine, as a potential neurodegenerative agent, may have a pivotal role in the regulation of oxidative stress, inflammation and apoptosis; and NSAIDs, such as mefenamic acid, may assist other therapeutics in treating disorders where d-serine-induced neurotoxic mechanisms are involved in.

Download full-text PDF

Source
http://dx.doi.org/10.3109/10715762.2012.669836DOI Listing

Publication Analysis

Top Keywords

mefenamic acid
24
oxidative stress
16
acid d-serine
8
stress inflammation
8
inflammation apoptosis
8
d-serine potential
8
levels tnf-α
8
tnf-α il-1β
8
acid
6
d-serine
5

Similar Publications

Importance: Gestational exposure to nonsteroidal anti-inflammatory drugs (NSAIDs) may increase the risk of adverse fetal kidney outcomes. However, details regarding timing, specific NSAIDs, and long-term childhood kidney outcomes are limited.

Objective: To evaluate the association between gestational exposure to NSAIDs and the risk of chronic kidney disease (CKD) in childhood.

View Article and Find Full Text PDF

Calibration free approaches for rapid polymorph discrimination low frequency (THz) Raman spectroscopy.

Chem Commun (Camb)

December 2024

EPSRC Future Continuous Manufacturing and Advanced Crystallisation Research Hub, University of Strathclyde, 99 George Street, Glasgow, G1 1RD, UK.

Application of multivariate curve resolution to non-invasive Raman spectra has been investigated for rapid on-line analysis of crystallisation processes and high-throughput screening. Exploring quantification of mefenamic acid solid forms (form I, form II, and dimethylformamide solvate) from the Raman spectra indicated excellent agreement with off-line X-ray analysis.

View Article and Find Full Text PDF

Dual effects of mefenamic acid on the I molecular complex.

Br J Pharmacol

November 2024

Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada.

Article Synopsis
  • - Mefenamic acid, a non-steroidal anti-inflammatory drug, can both enhance and inhibit cardiac ion currents formed by KCNQ1 and KCNE1 channels, revealing its dual effect on these channels, especially in patients with long and short QT syndromes.
  • - The study used whole cell patch clamp techniques and molecular dynamics simulations to investigate how mefenamic acid interacts with these channels, particularly noting its inhibition at high concentrations and its potential to preserve some current potentiation effects.
  • - Findings emphasize the importance of specific structural regions in the KCNQ1/KCNE1 channels that influence how drugs like mefenamic acid affect ion current, which has significant implications for developing treatments for certain genetic long QT syndrome mutations.*
View Article and Find Full Text PDF

Assessing plasmatic transport inhibitors of thyroid hormone in mammals in the Xenopus Eleutheroembryonic Thyroid Assay (XETA).

Environ Sci Pollut Res Int

November 2024

BASF SE, Agricultural Solutions - Ecotoxicology, Speyerer Strasse 2, 67117, Limburgerhof, Germany.

The Xenopus Eleutheroembryonic Thyroid Assay (XETA, OECD TG 248) was established as an alternative to the Amphibian Metamorphosis Assay (AMA, OECD TG 231) for the analysis of (anti-)thyroid activity of chemicals. The XETA is a New Approach Method (NAM) since the embryonic life stages used in the assay are not yet feeding independently, which renders the assay to be considered a non-animal test under many national laws. Physiologically, the used embryos are not fully developed yet, and thus there are limitations to the XETA for detecting certain mechanisms along the hypothalamic-pituitary-thyroid (HPT) axis.

View Article and Find Full Text PDF

: The study explores the potential of various deep eutectic solvents (DESs) to serve as drug delivery systems and pharmaceutical excipients. The research focuses on two primary objectives: evaluating the ability of the selected DES systems to enhance the solubility of two poorly water-soluble model drugs (IBU and MFA), and evaluating their physicochemical properties, including density, viscosity, flow behavior, surface tension, thermal stability, and water dilution effects, to determine their suitability for pharmaceutical applications. : A range of DES systems containing pharmaceutically acceptable constituents was explored, encompassing organic acid-based, sugar- and sugar alcohol-based, and hydrophobic systems, as well as menthol (MNT)-based DES systems with common pharmaceutical excipients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!